Therapeutic Solutions International Releases "IsoStilbene" Injectable Formulation of Pterostilbene Under Granted Patent for Augmentation of Immunotherapy and Targeting of Cancer Stem Cells
June 25, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today the formulation and initial clinical...
Therapeutic Solutions International Announces the Appointment of James Veltmeyer, MD as Chief Medical Officer
June 18, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) previously announced their plans to provide access to its...
Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" into StemVacs Dendritic Cell Platform
June 11, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire --Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today initiation of efforts to combine its existing...
Therapeutic Solutions International Announces Licensing of Additional Technologies to Pan American Cancer Treatment Center
June 06, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today their plans to license Pan Am four additional...
Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law
May 31, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today their plans to provide access to its clinical...
Therapeutic Solutions International Releases "DermalStilbene" a Topical Formulation of Pterostilbene
May 21, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today the availability of a topical form of...
Therapeutic Solutions International, Inc., to Initiate Clinical Trial of Patented Cancer Immunotherapy Adjuvant NanoStilbene
May 15, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire –Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today Institutional Review Board (IRB) clearance to...
Therapeutic Solutions International, Inc., Announces the Appointment of Nassir Azimi, MD, to Science Board
May 09, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company to Initiate Investigational Cardiovascular Study with Dr. Azimi and NanoStilbene OCEANSIDE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International,...
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Centers
May 01, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform withPatented Augmenter of Cancer Immunotherapy NanoStilbene OCEANSIDE, Calif., May 01, 2018 ...
Therapeutic Solutions International Develops "NanoStilbene" Nanoparticle Formulation of Pterostilbene
March 05, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--Therapeutics Solutions International, Inc., (OTC PINK:TSOI) announced today successful production of a stable nanoemulsion of...